National Wealth Management Group LLC Invests $436,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

National Wealth Management Group LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, HoldingsChannel reports. The institutional investor acquired 836 shares of the medical equipment provider’s stock, valued at approximately $436,000.

Other large investors also recently bought and sold shares of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the 4th quarter worth $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Summit Securities Group LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $31,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.7 %

Shares of ISRG stock opened at $495.27 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $176.40 billion, a P/E ratio of 77.27, a P/E/G ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average of $554.33 and a 200 day moving average of $532.98.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Citigroup increased their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Finally, Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Activity

In other news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.